SCHEMBL7590744

SCHEMBL7590744

CC(=O)N1[C@H](C)CC(=O)C[C@@H]1c1cccnc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
CYP3A4 P08684 1/20 0.46
THRB P10828 1/20 0.46
TSHR P16473 1/20 0.46
THPO P40225 1/20 0.46
MEN1 O00255 1/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CHRNA7 P36544 4/20 0.45
CHRNB2 P17787 4/20 0.45
CHRNA4 P43681 4/20 0.45
ALDH1A1 P00352 3/20 0.45
CHRNB4 P30926 2/20 0.45
CHRNA3 P32297 2/20 0.45
CHRNA2 Q15822 2/20 0.45
LMNA P02545 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HTR3E A5X5Y0 1/20 0.45
PSIP1 O75475 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7590741 1.00 KDM4E (0.46) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL7679889 0.83 CHRNA7 (0.52) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL7589470 0.80 CHRNA7 (0.47) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL27473681 0.80 CHRNA7 (0.47) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL7589466 0.80 CHRNA7 (0.47) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL7590540 0.79 CHRNA7 (0.46) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL7684465 0.79 CHRNA7 (0.46) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL1490988 0.77 KDM4E (0.59) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL7681930 0.76 CHRNA7 (0.43) KDM4ECYP3A4THRBTSHRTHPO
SCHEMBL7594374 0.76 CHRNA7 (0.43) KDM4ECYP3A4THRBTSHRTHPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020042413-A1 1-aza-2-alkyl-6-aryl-cycloalkanes RAULT SYLVAIN (FR) 2002-04-11 US disclosed
US-6323222-B1 COGNITION ACTIVATORS, ALZHEIMER*S DISEASE AND ENZYME INHIBITORS ADIR ET COMPAGNIE (FR) 2001-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042413-A1 1-aza-2-alkyl-6-aryl-cycloalkanes SULT2A1, GRIN2A, NR3C1 KDM4E 1889/4885CYP3A4 91/4885THRB 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.